NCT04717466View on ClinicalTrials.gov

Brain Changes in Psoriasis After Secukinumab Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 29, 2021

Primary Completion Date

May 16, 2024

Study Completion Date

March 4, 2025

Conditions
PsoriasisHealthy
Interventions
BIOLOGICAL

Secukinumab

300mg subcutaneous injection

Trial Locations (1)

33136

University of Miami, Miami

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

University of Miami

OTHER